Tag: Rybrevant
Johnson & Johnson: Requests FDA approval for Rybrevant
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Johnson & Johnson: Application for Marketing Authorization in the EU for Rybrevant
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Johnson & Johnson: Requests an expanded indication for Rybrevant
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Johnson & Johnson: Requests the EMA to expand the indication of Rybrevant
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Johnson & johnson: Seeks expanded indication for Rybrevant
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
J&J: seeks expanded indication for Rybrevant
(CercleFinance.com) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it has applied to the FDA to seek expanded approval for Rybrevant® (amivantamab-vmjw) in combination with chemotherapy…